Peking University First Hospital Researchers Advance Knowledge in Immunotherapy (Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy)

Media coverage

• Title	Peking University First Hospital Researchers Advance Knowledge in Immunotherapy (Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	01/3/25
  Persons	Y. Lynn Wang